"10.1371_journal.pone.0068328","plos one","2013-07-05T00:00:00Z","Karen Rex; Shawn Jeffries; Matthew L Brown; Timothy Carlson; Angela Coxon; Flordeliza Fajardo; Brendon Frank; Darin Gustin; Alexander Kamb; Paul D Kassner; Shyun Li; Yihong Li; Kurt Morgenstern; Matthew Plant; Kim Quon; Astrid Ruefli-Brasse; Joanna Schmidt; Elissa Swearingen; Nigel Walker; Zhulun Wang; J E Vivienne Watson; Dineli Wickramasinghe; Mariwil Wong; Guifen Xu; Holger Wesche","Oncology Research, Amgen Inc., Thousand Oaks, California, United States of America; Medicinal Chemistry, Amgen Inc., South San Francisco, California, United States of America; Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, California, United States of America; Discovery Sciences, Amgen Inc., South San Francisco, California, United States of America; Genome Analysis Unit, Amgen Inc., South San Francisco, California, United States of America; Molecular Structure and Characterization, Amgen Inc., Cambridge, Massachusetts, United States of America; Therapeutic Innovation Unit, Amgen Inc., Seattle, Washington, United States of America","Conceived and designed the experiments: KR TC KM HW. Performed the experiments: KR BF SL KM MP JS MW GX FF ES. Analyzed the data: KR SJ TC AC BF AK SL KM MP NW DW MW GX HW PK KQ VW JW. Contributed reagents/materials/analysis tools: YL DG ZW NW ARB MB. Wrote the paper: HW.","All authors have an affiliation to the commercial funder of this research (Amgen Inc.). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Karen Rex","KR",25,TRUE,4,10,18,1,TRUE,TRUE,FALSE,0,NA,FALSE
